907969-24-8 Usage
Description
[2-(2,3-DIHYDRO-1H-INDOL-3-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound characterized by the molecular formula C14H21N3O3. It is a tert-butyl ester derivative of carbamic acid, which is utilized in the synthesis of pharmaceuticals and pesticides. [2-(2,3-DIHYDRO-1H-INDOL-3-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER is widely recognized in the field of organic chemistry as a reagent for the synthesis of various indole derivatives. Its distinctive structure and properties render it an invaluable resource for researchers and scientists engaged in organic synthesis and drug development.
Uses
Used in Organic Chemistry:
[2-(2,3-DIHYDRO-1H-INDOL-3-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER is used as a reagent for the synthesis of indole derivatives, which are important in the development of pharmaceuticals and other organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, [2-(2,3-DIHYDRO-1H-INDOL-3-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER is used as a key intermediate in the synthesis of various drugs, contributing to the development of new medications and therapies.
Used in Pesticide Synthesis:
[2-(2,3-DIHYDRO-1H-INDOL-3-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER is also utilized in the synthesis of pesticides, playing a role in the creation of effective and environmentally responsible pest control solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 907969-24-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,7,9,6 and 9 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 907969-24:
(8*9)+(7*0)+(6*7)+(5*9)+(4*6)+(3*9)+(2*2)+(1*4)=218
218 % 10 = 8
So 907969-24-8 is a valid CAS Registry Number.
907969-24-8Relevant articles and documents
FUSED THIAZOLOPYRIMIDINE DERIVATIVES AS MNKS INHIBITORS
-
, (2017/06/12)
The present invention relates to compounds of formulae I and H, or pharmaceutically acceptable salts or esters thereof. Further aspects of the invention relate to pharmaceutical compositions and therapeutic uses of said compounds in the treatment of diseases of uncontrolled cell growth, proliferation and/or survival, inappropriate cellular immune responses, inappropriate cellular inflammatory responses, or neurodegenerative disorders, preferably tauopathies, even more preferably, Alzheimer's disease.
